Attached files

file filename
EX-23.1 - EXHIBIT 23.1 - BioCrude Technologies USA, Inc.s104814_ex23-1.htm
EX-10.14 - EXHIBIT 10.14 - BioCrude Technologies USA, Inc.s104814_ex10-14.htm
EX-10.13 - EXHIBIT 10.13 - BioCrude Technologies USA, Inc.s104814_ex10-13.htm
EX-10.12 - EXHIBIT 10.12 - BioCrude Technologies USA, Inc.s104814_ex10-12.htm
EX-10.11 - EXHIBIT 10.11 - BioCrude Technologies USA, Inc.s104814_ex10-11.htm
EX-10.10 - EXHIBIT 10.10 - BioCrude Technologies USA, Inc.s104814_ex10-10.htm
EX-10.9 - EXHIBIT 10.9 - BioCrude Technologies USA, Inc.s104814_ex10-9.htm
EX-10.8 - EXHIBIT 10.8 - BioCrude Technologies USA, Inc.s104814_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - BioCrude Technologies USA, Inc.s104814_ex10-7.htm
EX-3.3 - EXHIBIT 3-3 - BioCrude Technologies USA, Inc.s104814_ex3-3.htm
EX-3.2 - EXHIBIT 3.2 - BioCrude Technologies USA, Inc.s104814_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - BioCrude Technologies USA, Inc.s104814_ex3-1.htm
S-1 - S-1 - BioCrude Technologies USA, Inc.s104814_s1.htm

Exhibit 5.1

 

 

 

November 30, 2016

Board of Directors

Biocrude Technologies USA, Inc.

1255 Phillips Square, Suite 605

Montreal, QB, CANADA H3B 3G5

 

Re: Registration Statement on Form S-1 for Biocrude Technologies USA, Inc.,
  a Nevada corporation (the "Company")

 

Dear Ladies and Gentlemen:

 

This opinion is submitted pursuant to the applicable rules of the Securities and Exchange Commission with respect to the registration of 6,699,343 shares held by existing shareholders and 20,000,000 newly issued shares for public sale of the Company's common stock, $.001 par value, to be sold by the existing selling shareholders and the issuer.

 

In connection therewith, I have examined and relied upon original, certified, conformed, Photostat or other copies of the following documents:

 

  i. The Certificate of Incorporation of the Company;
  ii. The Registration Statement and the Exhibits thereto; and
  iii. Such other documents and matters of law, as I have deemed necessary for the expression of the opinion herein contained.

 

In all such examinations, I have assumed the genuineness of all signatures on original documents, and the conformity to the originals or certified documents of all copies submitted to me as conformed, Photostat or other copies. In passing upon certain corporate records and documents of the Company, I have necessarily assumed the correctness and completeness of the statements made or included therein by the Company, and I express no opinion thereon. As to the various questions of fact material to this opinion, I have relied, to the extent I deemed reasonably appropriate, upon representations or certificates of officers or directors of the Company and upon documents, records and instruments furnished to me by the Company, without verification except where such verification was readily ascertainable. 

 

1212 S. Casino Center, Las Vegas, Nevada 89104

Telephone: (702) 382-1714 ¨ Facsimile: (702) 382-1759

E-Mail: harold@gewerterdowling.com

 

 

 

 

Re: Biocrude

Nov. 30, 2016

Page 2

 

Based on the foregoing, I am of the opinion that (i) the 20,000,000 shares to be offered by the company will when sold be legally issued, fully paid and non-assessable, and (ii) the 6,699,343 shares held by the selling shareholder are and will be when sold in this offering be legally issued, fully paid and non-assessable.

 

This opinion is limited to the laws of the State of Nevada and federal law as in effect on the date of the effectiveness of this registration statement.

 

I hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of my name under the caption "Interests of Named Experts and Counsel" in the prospectus comprising part of the Registration Statement.

 

  Sincerely yours,
   
  HAROLD P. GEWERTER, ESQ., LTD.
   
  /s/ Harold P. Gewerter, Esq.
   
  Harold P. Gewerter, Esq.